Amorphous Silicon Nanostructures with Bridges
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge lies in creating ordered and freestanding Si-based mesostructures with molecular-level principal feature sizes less than 10 nm, which are difficult to achieve using nano-casting synthesis due to the need for high-quality and controllable electrical or optical properties, particularly in biomedical applications where biocompatibility and biodegradability are essential.
Innovation Solution
The development of silicon-based materials comprising an aggregate of particles with an ordered array of nanostructures connected by amorphous silicon bridges, synthesized using a mesoporous silica template via chemical vapor deposition, allowing for the creation of biocompatible and biodegradable materials with multiscale structural and chemical heterogeneities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If nano-casting synthesis is used to create Si-based mesostructures, then scalability and versatility are improved, but achieving molecular-level feature sizes less than 10 nm with high quality and controllable electrical properties becomes difficult
Solution Approach 1:
The patent changes the deposition parameters including temperature (400-600°C), pressure (1-100 Torr), and deposition time to precisely control the silicon layer thickness and nanowire diameter, achieving feature sizes less than 10 nm while maintaining scalability through systematic parameter optimization
Solution Approach 2:
The patent uses mesoporous silica templates as intermediaries to define the nanoscale structure. The templates with controlled pore sizes (2-10 nm) serve as molds that guide silicon deposition, enabling precise molecular-level feature size control while the templating approach remains scalable to large quantities
2Reliability
If single crystalline structures are used, then high quality electrical and optical properties are achieved, but biocompatibility and biodegradability required for biomedical applications are lost
Solution Approach 1:
The patent creates composite structures combining amorphous silicon nanowires with biocompatible coatings such as silicon oxide, silicon nitride, or polymer layers. This composite approach maintains the electrical functionality of silicon while adding biocompatibility and biodegradability for biomedical applications
Solution Approach 2:
The patent transitions from single crystalline to amorphous silicon structure, changing the material phase to achieve a balance between electrical properties and biocompatibility. The amorphous structure with controlled nanoscale morphology provides both functional performance and biomedical suitability
3Reliability
If amorphous silicon nanostructures are connected by bridges, then electrical conductivity is improved, but structural complexity increases
Solution Approach 1:
The patent merges adjacent silicon nanowires through amorphous silicon bridges formed by controlled deposition. The bridges connect discrete nanostructures into continuous conductive networks, improving electrical conductivity while the self-forming nature of the bridges during deposition limits unnecessary complexity
Data Source
AI summary
Provided herein are Si-based materials, methods of making the Si-based materials, and methods for using the Si-based materials. In embodiments, a silicon-based material comprises an aggregate of particles, the particles comprising an ordered array of nanostructures, the nanostructures comprising amorphous silicon, wherein at least some pairs of adjacent nanostructures are connected by one or more bridges comprising amorphous silicon, the one or more bridges extending from the surface of one nanostructure of the pair to the surface of the other nanostructure in the pair.